|
 |
|
|
|
|
|
Speakers We are now inviting the speaker panel for the Cell & Gene Therapy Forum 2009. Amongst those high profile figures who have already confirmed their participation are: David G. Nance, Chairman, President & CEO, Introgen Therapeutics, Inc Professor Ryuichi Morishita, Professor, Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine & Board Member, AnGes MG Dr C. Randall Mills, President & CEO, Osiris Therapeutics, Inc Dr Mitchell H. Gold, President & CEO, Dendreon Corporation H. Stewart Parker, President & CEO, Targeted Genetics Corporation Shosh Merchav, PhD, MBA, Director, Head, Cell Therapy Projects, Teva Innovative Venture, Teva Pharmaceutical Industries Ltd Edward Lanphier, President & CEO, Sangamo BioSciences, Inc Dr Jane S. Lebkowski, Senior Vice President, Regenerative Medicine, Geron Corporation Paul J. Schmitt, Managing Director, Novitas Capital Gabor M. Rubanyi MD, PhD, Chief Scientific Officer, Cardium Therapeutics, Inc Dr Ann Tsukamoto, COO, StemCells, Inc Carol Grundfest, Senior Vice President, Regulatory Affairs & Portfolio Management, Cell Genesys, Inc Gregory A. Bonfiglio, Managing Partner, Proteus Venture Partners Andrew L. Pecora, MD, Chairman of the Board, Acting CEO, Amorcyte Christine V. Sapan, PhD, Executive Vice President & Chief Development Officer, Neurologix, Inc Professor Sander van Deventer, CSO, AMT BV Henrik Ørum, MSc, PhD, Vice President & CSO, Santaris Pharma A/S Elyse Seltzer, MD, Chief Medical Officer, Vice President, Clinical Development & Medical Affairs, Tengion, Inc Dr Kai Pinkernell, Senior Director, Regenerative Cell Technology, Cytori Therapeutics, Inc Michael Covington, Senior Director of Quality Assurance, Dendreon Corporation Marco Dieci, BSc, Quality & Regulatory Director, Qualified Person, MolMed SpA Dr Penny Johnson, Director of Research, UK, Intercytex Ltd Visit this page again soon to find out who else you will be able to hear from – and meet – in Washington this coming January.
|
